NOVAVAX INC: accounts_receivable
| Value | {"amount": 2859000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2014-09-30) |
| Status | current |
| Entity | NOVAVAX INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:02.413114+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4be0b3c3-93c7-4367-a506-b5b3b383a170
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-14-065719Retrieved: 2026-08-19T09:41:02.413114+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001000694/accounts-receivable/2014-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4be0b3c3-93c7-4367-a506-b5b3b383a170
History
- no predecessors — first report